Clinical Trial Update: Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating soblidotin in patients with advanced or metastatic soft tissue sarcoma, sponsored by Daiichi S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• soblidotin (soblidotin)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Sarcoma | Phase 2 | Status: COMPLETED